BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32442850)

  • 21. Active conformation of some arylpiperazine postsynaptic 5-HT(1A) receptor antagonists.
    Paluchowska MH; Bojarski AJ; Charakchieva-Minol S; Wesołowska A
    Eur J Med Chem; 2002 Apr; 37(4):273-83. PubMed ID: 11960662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [1]Benzothieno[3,2-d]pyrimidine derivatives as ligands for the serotonergic 5-HT
    Romeo G; Salerno L; Pittalà V; Candido M; Intagliata S; Amata E; Salmona M; Cagnotto A; Rescifina A; Floresta G; Modica MN
    Eur J Med Chem; 2019 Dec; 183():111690. PubMed ID: 31526973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents.
    Leopoldo M; Berardi F; Colabufo NA; Contino M; Lacivita E; Niso M; Perrone R; Tortorella V
    J Med Chem; 2004 Dec; 47(26):6616-24. PubMed ID: 15588097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of novel 5-substituted-2-aminotetralin analogs: 5-HT
    Perry CK; Casey AB; Felsing DE; Vemula R; Zaka M; Herrington NB; Cui M; Kellogg GE; Canal CE; Booth RG
    Bioorg Med Chem; 2020 Feb; 28(3):115262. PubMed ID: 31882369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), alpha1-adrenergic, and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics.
    Bojarski AJ; Paluchowska MH; Duszyńska B; Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E
    Bioorg Med Chem; 2005 Mar; 13(6):2293-303. PubMed ID: 15727878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of the halogen bonding on D
    Partyka A; Kurczab R; Canale V; Satała G; Marciniec K; Pasierb A; Jastrzębska-Więsek M; Pawłowski M; Wesołowska A; Bojarski AJ; Zajdel P
    Bioorg Med Chem; 2017 Jul; 25(14):3638-3648. PubMed ID: 28529043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aryl biphenyl-3-ylmethylpiperazines as 5-HT7 receptor antagonists.
    Kim J; Kim Y; Tae J; Yeom M; Moon B; Huang XP; Roth BL; Lee K; Rhim H; Choo IH; Chong Y; Keum G; Nam G; Choo H
    ChemMedChem; 2013 Nov; 8(11):1855-64. PubMed ID: 24039134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-basicity 5-HT
    Hogendorf AS; Hogendorf A; Kurczab R; Satała G; Lenda T; Walczak M; Latacz G; Handzlik J; Kieć-Kononowicz K; Wierońska JM; Woźniak M; Cieślik P; Bugno R; Staroń J; Bojarski AJ
    Sci Rep; 2017 May; 7(1):1444. PubMed ID: 28473721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arylpiperazine derivatives acting at 5-HT(1A) receptors.
    López-Rodríguez ML; Ayala D; Benhamú B; Morcillo MJ; Viso A
    Curr Med Chem; 2002 Feb; 9(4):443-69. PubMed ID: 11945120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding modes of chain arylpiperazines to 5-HT1a, 5-HT2a and 5-HT7 receptors.
    Bielenica A; Kozioł AE; Struga M
    Mini Rev Med Chem; 2013 Aug; 13(10):1516-39. PubMed ID: 24568298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement in the selectivity and metabolic stability of the serotonin 5-HT(1A) ligand, S 15535: a series of cis- and trans-2-(arylcycloalkylamine) 1-indanols.
    Peglion JL; Goument B; Despaux N; Charlot V; Giraud H; Nisole C; Newman-Tancredi A; Dekeyne A; Bertrand M; Genissel P; Millan MJ
    J Med Chem; 2002 Jan; 45(1):165-76. PubMed ID: 11754589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-activity relationship studies of CNS agents, Part 31: Analogs of MP 3022 with a different number of nitrogen atoms in the heteroaromatic fragment--new 5-HT1A receptor ligands.
    Paluchowska MH; Dereń-Wesołek A; Mokrosz JL; Charakchieva-Minol S; Chojnacka-Wójcik E
    Arch Pharm (Weinheim); 1996 Oct; 329(10):451-6. PubMed ID: 8933747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solid-Supported Synthesis and 5-HT7 /5-HT1A Receptor Affinity of Arylpiperazinylbutyl Derivatives of 4,5-dihydro-1,2,4-triazine-6-(1H)-one.
    Grychowska K; Masurier N; Verdié P; Satała G; Bojarski AJ; Martinez J; Pawłowski M; Subra G; Zajdel P
    Chem Biol Drug Des; 2015 Oct; 86(4):697-703. PubMed ID: 25684690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and synthesis of new homo and hetero bis-piperazinyl-1-propanone derivatives as 5-HT7R selective ligands over 5-HT1AR.
    Intagliata S; Modica MN; Pittalà V; Salerno L; Siracusa MA; Cagnotto A; Salmona M; Romeo G
    Bioorg Med Chem Lett; 2016 Aug; 26(16):4052-6. PubMed ID: 27396505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2a-[4-(Tetrahydropyridoindol-2-yl)butyl]tetrahydrobenzindole derivatives: new selective antagonists of the 5-hydroxytryptamine7 receptor.
    Kikuchi C; Ando T; Watanabe T; Nagaso H; Okuno M; Hiranuma T; Koyama M
    J Med Chem; 2002 May; 45(11):2197-206. PubMed ID: 12014957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-activity relationships of serotonin 5-HT
    Thirumaran SL; Lepailleur A; Rochais C
    Eur J Med Chem; 2019 Dec; 183():111705. PubMed ID: 31581003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and pharmacological evaluation of new arylpiperazines. 3-[4-[4-(3-chlorophenyl)-1-piperazinyl]butyl]-quinazolidin-4-one - a dual serotonin 5-HT(1A)/5-HT(2A) receptor ligand with an anxiolytic-like activity.
    Bojarski AJ; Kowalski P; Kowalska T; Duszyńska B; Charakchieva-Minol S; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E
    Bioorg Med Chem; 2002 Dec; 10(12):3817-27. PubMed ID: 12413835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A synthetic overview of new molecules with 5-HT1A binding affinities.
    Pessoa-Mahana H; Araya-Maturana R; Saitz CB; Pessoa-Mahana DC
    Mini Rev Med Chem; 2003 Mar; 3(2):77-93. PubMed ID: 12570842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Labeling and preliminary in vivo evaluation of the 5-HT(7) receptor selective agonist [(11)C]E-55888.
    Hansen HD; Andersen VL; Lehel S; Magnussen JH; Dyssegaard A; Stroth N; Kristensen JL; Knudsen GM; Herth MM
    Bioorg Med Chem Lett; 2015 May; 25(9):1901-4. PubMed ID: 25857944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of spacer structure on 5-HT7 and 5-HT1A receptor affinity in the group of long-chain arylpiperazine ligands.
    Bojarski AJ; Duszyńska B; Kołaczkowski M; Kowalski P; Kowalska T
    Bioorg Med Chem Lett; 2004 Dec; 14(23):5863-6. PubMed ID: 15501057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.